Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 367157, 9 pages
http://dx.doi.org/10.1155/2014/367157
Research Article

MicroRNA Expression Profiling in PBMCs: A Potential Diagnostic Biomarker of Chronic Hepatitis C

1Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
2Division of Gastroenterology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
3School of Medicine, Chung Shan Medical University, Taichung, Taiwan
4Department of Pathology, Chung Shan Medical University, Taichung, Taiwan
5Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 115, Taiwan

Received 1 July 2014; Revised 11 September 2014; Accepted 27 September 2014; Published 18 November 2014

Academic Editor: Vincent Sapin

Copyright © 2014 Chiu-Chun Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Mengshol, L. Golden-Mason, and H. R. Rosen, “Mechanisms of disease: HCV-induced liver injury,” Nature Clinical Practice Gastroenterology & Hepatology, vol. 4, no. 110, pp. 622–634, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. R.-X. Shao, Y. Hoshida, M. Otsuka et al., “Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients,” World Journal of Gastroenterology, vol. 11, no. 13, pp. 1995–1999, 2005. View at Google Scholar · View at Scopus
  3. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Lagos-Quintana, R. Rauhut, A. Yalcin, J. Meyer, W. Lendeckel, and T. Tuschl, “Identification of tissue-specific MicroRNAs from mouse,” Current Biology, vol. 12, no. 9, pp. 735–739, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Ason, D. K. Darnell, B. Wittbrodt et al., “Differences in vertebrate microRNA expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 39, pp. 14385–14389, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood-based markers for cancer detection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Wang, S. Zhang, B. Marzolf et al., “Circulating microRNAs, potential biomarkers for drug-induced liver injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 11, pp. 4402–4407, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. L. Jopling, M. Yi, A. M. Lancaster, S. M. Lemon, and P. Sarnow, “Molecular biology: modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA,” Science, vol. 309, no. 5740, pp. 1577–1581, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Murakami, H. H. Aly, A. Tajima, I. Inoue, and K. Shimotohno, “Regulation of the hepatitis C virus genome replication by miR-199a,” Journal of Hepatology, vol. 50, no. 3, pp. 453–460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Bala, M. Marcos, and G. Szabo, “Emerging role of microRNAs in liver diseases,” World Journal of Gastroenterology, vol. 15, no. 45, pp. 5633–5640, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Peng, Y. Li, K.-A. Walters et al., “Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers,” BMC Genomics, vol. 10, article 373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. J. Atkinson Jr., W. A. Colburn, V. G. DeGruttola et al., “Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Biomarkers Definitions Working Group,” Clinical Pharmacology & Therapeutics, vol. 69, no. 3, pp. 89–95, 2001. View at Google Scholar
  13. J. Woodcock, A Framework for Biomarker and Surrogate Endpoint Use in Drug Development, http://www.fda.gov/ohrms/dockets/ac/04/slides/2004-4079S2_03_Woodcock.ppt.
  14. National Cancer Institute, Dictionary of Cancer Terms, http://www.cancer.gov/dictionary/?searchTxt=biomarker.
  15. M. J. Koziel, “The role of immune responses in the pathogenesis of hepatitis C virus infection,” Journal of Viral Hepatitis, vol. 4, supplement 2, pp. 31–41, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Bala, Y. Tilahun, O. Taha et al., “Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection,” Journal of Translational Medicine, vol. 10, no. 1, article 151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. R. S. Tacke, A. Tosello-Trampont, V. Nguyen, D. W. Mullins, and Y. S. Hahn, “Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway,” The Journal of Biological Chemistry, vol. 286, no. 12, pp. 10847–10855, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Grek, A. Piekarska, J. Bartkowiak et al., “Coordinated increase of miRNA-155 and miRNA-196b expression correlates with the detection of the antigenomic strand of hepatitis C virus in peripheral blood mononuclear cells,” International Journal of Molecular Medicine, vol. 28, no. 5, pp. 875–880, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Otaegui, S. E. Baranzini, R. Armañanzas et al., “Differential micro RNA expression in PBMC from multiple sclerosis patients,” PLoS ONE, vol. 4, no. 7, Article ID e6309, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Szabo and S. Bala, “MicroRNAs in liver disease,” Nature Reviews Gastroenterology & Hepatology, vol. 10, no. 11, pp. 542–552, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Randall, M. Panis, J. D. Cooper et al., “Cellular cofactors affecting hepatitis C virus infection and replication,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 31, pp. 12884–12889, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Murakami, A. Tamori, S. Itami et al., “The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis,” BMC Cancer, vol. 13, article 99, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhang, S. Takahashi, A. Tasaka, T. Yoshima, H. Ochi, and K. Chayama, “Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma,” Journal of Gastroenterology and Hepatology, vol. 28, no. 3, pp. 565–575, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Lendvai, A. Kiss, I. Kovalszky, and Z. Schaff, “MicroRNAs in hepatocarcinogenesis,” Orvosi Hetilap, vol. 153, no. 25, pp. 978–989, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Karakatsanis, I. Papaconstantinou, M. Gazouli, A. Lyberopoulou, G. Polymeneas, and D. Voros, “Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance,” Molecular Carcinogenesis, vol. 52, no. 4, pp. 297–303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Papaconstantinou, A. Karakatsanis, M. Gazouli, G. Polymeneas, and D. Voros, “The role of microRNAs in liver cancer,” European Journal of Gastroenterology and Hepatology, vol. 24, no. 3, pp. 223–228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Chen, Y. Ba, L. Ma et al., “Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases,” Cell Research, vol. 18, no. 10, pp. 997–1006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. P. Hunter, N. Ismail, X. Zhang et al., “Detection of microRNA expression in human peripheral blood microvesicles,” PLoS ONE, vol. 3, no. 11, Article ID e3694, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood based markers for cancer detection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Google Scholar
  30. S. Gilad, E. Meiri, Y. Yogev et al., “Serum microRNAs are promising novel biomarkers,” PLoS ONE, vol. 3, no. 9, Article ID e3148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. Cortez and G. A. Calin, “MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases,” Expert Opinion on Biological Therapy, vol. 9, no. 6, pp. 703–711, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. J. A. Weber, D. H. Baxter, S. Zhang et al., “The microRNA spectrum in 12 body fluids,” Clinical Chemistry, vol. 56, no. 11, pp. 1733–1741, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Adachi, M. Nakanishi, Y. Otsuka et al., “Plasma microRNA 499 as a biomarker of acute myocardial infarction,” Clinical Chemistry, vol. 56, no. 7, pp. 1183–1185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Ai, R. Zhang, Y. Li et al., “Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction,” Biochemical and Biophysical Research Communications, vol. 391, no. 1, pp. 73–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Widera, S. K. Gupta, J. M. Lorenzen et al., “Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome,” Journal of Molecular and Cellular Cardiology, vol. 51, no. 5, pp. 872–875, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Menghini, V. Casagrande, and M. Federici, “MicroRNAs in endothelial senescence and atherosclerosis,” Journal of Cardiovascular Translational Research, vol. 6, no. 6, pp. 924–930, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Huang, Q. Hu, Z. Deng, Y. Hang, J. Wang, and K. Wang, “Micrornas in body fluids as biomarkers for non-small cell lung cancer: a systematic review,” Technology in Cancer Research & Treatment, vol. 13, no. 3, pp. 277–287, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Cheng, C. Y. J. Quek, X. Sun, S. A. Bellingham, and A. F. Hill, “The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies,” Frontiers in Genetics, vol. 4, article 150, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Dorval, P. T. Nelson, and S. S. Hébert, “Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers,” Frontiers in Molecular Neuroscience, vol. 6, article 24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. X.-F. Jin, N. Wu, L. Wang, and J. Li, “Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases,” Cellular and Molecular Neurobiology, vol. 33, no. 5, pp. 601–613, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. K. S. Sheinerman and S. R. Umansky, “Circulating cell-free microRNA as biomarkers for screening, diagnosis, and monitoring of neurodegenerative diseases and other neurologic pathologies,” Frontiers in Cellular Neuroscience, vol. 7, Article ID 150, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. O. Babalola, A. Mamalis, H. Lev-Tov, and J. Jagdeo, “The role of microRNAs in skin fibrosis,” Archives of Dermatological Research, vol. 305, no. 9, pp. 763–776, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Gonzalez, “Osteoarthritis year 2013 in review: genetics and genomics,” Osteoarthritis and Cartilage, vol. 21, no. 10, pp. 1443–1451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. X. Chen, Y. Ba, L. Ma et al., “Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases,” Cell Research, vol. 18, no. 10, pp. 997–1006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Cermelli, A. Ruggieri, J. A. Marrero, G. N. Ioannou, and L. Beretta, “Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease,” PLoS ONE, vol. 6, no. 8, Article ID e23937, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. F. Ji, B. Yang, X. Peng, H. Ding, H. You, and P. Tien, “Circulating microRNAs in hepatitis B virus-infected patients,” Journal of Viral Hepatitis, vol. 18, no. 7, pp. e242–e251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. R. T. Marquez, S. Bandyopadhyay, E. B. Wendlandt et al., “Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans,” Laboratory Investigation, vol. 90, no. 12, pp. 1727–1736, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. R. A. Nathwani, S. Pais, T. B. Reynolds, and N. Kaplowitz, “Serum alanine aminotransferase in skeletal muscle diseases,” Hepatology, vol. 41, no. 2, pp. 380–382, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Braconi, N. Valeri, P. Gasparini et al., “Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes,” Clinical Cancer Research, vol. 16, no. 3, pp. 957–966, 2010. View at Publisher · View at Google Scholar · View at Scopus